Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suchitra Rao

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
JAMA Network Open|March 15, 2023
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage PeriodsRuth Link-Gelles, Matthew E Levy, Karthik Natarajan, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022Nicola P Klein, Melissa S Stockwell, Maria Demarco, et al.
MMWR. Morbidity and Mortality Weekly Report|February 17, 2022
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
JAMA Internal Medicine|January 6, 2026
Estimated Burden of COVID-19 Illnesses, Medical Visits, Hospitalizations, and Deaths in the US From October 2022 to September 2024Emilia H A Koumans, Diba Khan, Imelda Trejo, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021Catherine H Bozio, Shaun J Grannis, Allison L Naleway, et al.
MMWR. Morbidity and Mortality Weekly Report|March 31, 2022
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022Karthik Natarajan, Namrata Prasad, Kristin Dascomb, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 30, 2021
Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021Peter J Embi, Matthew E Levy, Allison L Naleway, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021Peter J Embi, Matthew E Levy, Allison L Naleway, et al.
JAMA|July 30, 2025
Influenza-Associated Acute Necrotizing Encephalopathy in US Children, Andrew Silverman, Rachel Walsh, et al.
MMWR. Morbidity and Mortality Weekly Report|November 14, 2024
Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024Aaron M Frutos, Haris M Ahmad, Dawud Ujamaa, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
JAMA Network Open|March 15, 2023
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage PeriodsRuth Link-Gelles, Matthew E Levy, Karthik Natarajan, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022Nicola P Klein, Melissa S Stockwell, Maria Demarco, et al.
MMWR. Morbidity and Mortality Weekly Report|February 17, 2022
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
JAMA Internal Medicine|January 6, 2026
Estimated Burden of COVID-19 Illnesses, Medical Visits, Hospitalizations, and Deaths in the US From October 2022 to September 2024Emilia H A Koumans, Diba Khan, Imelda Trejo, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021Catherine H Bozio, Shaun J Grannis, Allison L Naleway, et al.
MMWR. Morbidity and Mortality Weekly Report|March 31, 2022
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022Karthik Natarajan, Namrata Prasad, Kristin Dascomb, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 30, 2021
Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021Peter J Embi, Matthew E Levy, Allison L Naleway, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021Peter J Embi, Matthew E Levy, Allison L Naleway, et al.
JAMA|July 30, 2025
Influenza-Associated Acute Necrotizing Encephalopathy in US Children, Andrew Silverman, Rachel Walsh, et al.
MMWR. Morbidity and Mortality Weekly Report|November 14, 2024
Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024Aaron M Frutos, Haris M Ahmad, Dawud Ujamaa, et al.
Pageof 15